Clinical Pharmacokinetic and Pharmacodynamic Considerations in the (Modern) Treatment of Melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2019 AND VI 58 AND IP 8
Results: 8
1
2
Revisiting the Pharmacology of Unfractionated Heparin.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Subjects with Hepatic Impairment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
5
Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein.
- Published in:
- 2019
- By:
- Publication type:
- journal article
6
Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
7
Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I-III Clinical Trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
8
Population-Pharmacokinetic Modeling of Tildrakizumab (MK-3222), an Anti-Interleukin-23-p19 Monoclonal Antibody, in Healthy Volunteers and Subjects with Psoriasis.
- Published in:
- 2019
- By:
- Publication type:
- journal article